Inger Gustavsson
Project manager at Department of Immunology, Genetics and Pathology; Research programme: Genomics and Neurobiology; Research group Ulf Gyllensten
- Telephone:
- +46 18 471 48 04
- Mobile phone:
- +46 70 167 92 77
- E-mail:
- inger.gustavsson@igp.uu.se
- Visiting address:
- BMC, Husargatan 3
751 22 Uppsala - Postal address:
- Box 815
751 08 Uppsala
More information is available to staff who log in.
Publications
Selection of publications
- Comparison of vaginal self-sampling and cervical sampling by medical professionals for the detection of HPV and CIN2+ (2021)
- Cost-effectiveness analysis of repeated self-sampling for HPV testing in primary cervical screening: a randomized study (2020)
- Temporal changes in the vaginal microbiota in self-samples and its association with persistent HPV16 infection and CIN2+ (2020)
- Diagnostic excision of the cervix in women over 40 years with human papilloma virus persistency and normal cytology (2019)
- HPV viral load in self-collected vaginal fluid samples as predictor for presence of cervical intraepithelial neoplasia. (2019)
- Invasive cervical tumors with high and low HPV titer represent molecular subgroups with different disease etiology (2019)
- Randomised study of HPV prevalence and detection of CIN2+ in vaginal self-sampling compared to cervical specimens collected by medical personnel. (2019)
- Clinical validation of the HPVIR high-risk HPV test on cervical samples according to the international guidelines for human papillomavirus DNA test requirements for cervical cancer screening (2019)
- Randomised study shows that repeated self-sampling and HPV test has more than two-fold higher detection rate of women with CIN2+ histology than Pap smear cytology (2018)
- Cervical dysplasia in elderly women performing repeated self-sampling for HPV testing (2018)
- Brush Biopsy For HR-HPV Detection With FTA Card And AI For Cytology Analysis - A Viable Non-invasive Alternative (2018)
- Daily self-sampling for high-risk human papillomavirus (HR-HPV) testing. (2015)
- Comprehensive profiling of the vaginal microbiome in HIV positive women using massive parallel semiconductor sequencing (2014)
- Uneven distribution of human papillomavirus 16111 cervical carcinoma in situ and squamous cell carcinoma in older females (2014)
- Genome-wide Association Study of Susceptibility Loci for Cervical Cancer (2013)
- Projected cost-effectiveness of repeat high-risk human papillomavirus testing using self-collected vaginal samples in the Swedish cervical cancer screening program (2013)
- Primary high-risk HPV screening for cervical cancer in post-menopausal women (2012)
- Multiply-primed rolling circle amplification of human papillomavirus using sequence-specific primers (2012)
- Detection of Human Papillomavirus Among Women in Laos Feasibility of Using Filter Paper Card and Prevalence of High-Risk Types (2012)
- Type-specific detection of high-risk human papillomavirus (HPV) in self-sampled cervicovaginal cells applied to FTA elute cartridge (2011)
- Short-time repeat high-risk HPV testing by self-sampling for screening of cervical cancer (2011)
- Comparison between the Hybrid Capture 2 and the hpVIR real-time PCR for detection of human papillomavirus in women with ASCUS or low grade dysplasia (2009)
- Use of FTA card for dry collection, transportation and storage of cervical cell specimen to detect high-risk HPV (2009)
- Polymorphisms in 9q32 and TSCOT are linked to cervical cancer in affected sib-pairs with high mean age at diagnosis (2008)
- Variants of chemokine receptor 2 and interleukin 4 receptor, but not interleukin 10 or Fas ligand, increase risk of cervical cancer (2007)
- Identification of susceptibility loci for cervical carcinoma by genome scan of affected sib-pairs (2006)
- High viral loads of human papillomavirus predict risk of invasive cervical carcinoma. (2005)
- Type-specific associations of human papillomavirus load with risk of developing cervical carcinoma in situ. (2004)
- Real-time PCR-based system for simultaneous quantification of human papillomavirus types associated with high risk of cervical cancer (2003)
Recent publications
- Toward ovarian cancer screening with protein biomarkers using dried, self-sampled cervico-vaginal fluid (2024)
- Incidence of oncogenic HPV and HPV-related dysplasia five years after a negative HPV test by self-sampling in elderly women (2022)
- Comparison of vaginal self-sampling and cervical sampling by medical professionals for the detection of HPV and CIN2+ (2021)
- Identification of Candidate Protein Biomarkers for CIN2+ Lesions from Self-Sampled, Dried Cervico-Vaginal Fluid Using LC-MS/MS (2021)
- Brush Samples of Oral Lesions to FTA Elute Card for High-risk Human Papilloma Virus Diagnosis (2021)
All publications
Articles
- Toward ovarian cancer screening with protein biomarkers using dried, self-sampled cervico-vaginal fluid (2024)
- Incidence of oncogenic HPV and HPV-related dysplasia five years after a negative HPV test by self-sampling in elderly women (2022)
- Comparison of vaginal self-sampling and cervical sampling by medical professionals for the detection of HPV and CIN2+ (2021)
- Identification of Candidate Protein Biomarkers for CIN2+ Lesions from Self-Sampled, Dried Cervico-Vaginal Fluid Using LC-MS/MS (2021)
- Brush Samples of Oral Lesions to FTA Elute Card for High-risk Human Papilloma Virus Diagnosis (2021)
- Cost-effectiveness analysis of repeated self-sampling for HPV testing in primary cervical screening: a randomized study (2020)
- Temporal changes in the vaginal microbiota in self-samples and its association with persistent HPV16 infection and CIN2+ (2020)
- Acceptability of self- collection for human papillomavirus detection in the Eastern Cape, South Africa (2020)
- Diagnostic excision of the cervix in women over 40 years with human papilloma virus persistency and normal cytology (2019)
- HPV viral load in self-collected vaginal fluid samples as predictor for presence of cervical intraepithelial neoplasia. (2019)
- Invasive cervical tumors with high and low HPV titer represent molecular subgroups with different disease etiology (2019)
- Randomised study of HPV prevalence and detection of CIN2+ in vaginal self-sampling compared to cervical specimens collected by medical personnel. (2019)
- Clinical validation of the HPVIR high-risk HPV test on cervical samples according to the international guidelines for human papillomavirus DNA test requirements for cervical cancer screening (2019)
- Randomised study shows that repeated self-sampling and HPV test has more than two-fold higher detection rate of women with CIN2+ histology than Pap smear cytology (2018)
- Cervical dysplasia in elderly women performing repeated self-sampling for HPV testing (2018)
- Daily self-sampling for high-risk human papillomavirus (HR-HPV) testing. (2015)
- Comprehensive profiling of the vaginal microbiome in HIV positive women using massive parallel semiconductor sequencing (2014)
- Uneven distribution of human papillomavirus 16111 cervical carcinoma in situ and squamous cell carcinoma in older females (2014)
- Genome-wide Association Study of Susceptibility Loci for Cervical Cancer (2013)
- Projected cost-effectiveness of repeat high-risk human papillomavirus testing using self-collected vaginal samples in the Swedish cervical cancer screening program (2013)
- Primary high-risk HPV screening for cervical cancer in post-menopausal women (2012)
- Multiply-primed rolling circle amplification of human papillomavirus using sequence-specific primers (2012)
- Detection of Human Papillomavirus Among Women in Laos Feasibility of Using Filter Paper Card and Prevalence of High-Risk Types (2012)
- Type-specific detection of high-risk human papillomavirus (HPV) in self-sampled cervicovaginal cells applied to FTA elute cartridge (2011)
- Short-time repeat high-risk HPV testing by self-sampling for screening of cervical cancer (2011)
- Ska HPV-test ersätta gynekologisk cellprovtagning hos kvinnor i menopaus? (2010)
- Conjugation of HPV16 E7 to cholera toxin enhances the HPV-specific T-cell recall responses to pulsed dendritic cells in vitro in women with cervical dysplasia (2010)
- Comparison between the Hybrid Capture 2 and the hpVIR real-time PCR for detection of human papillomavirus in women with ASCUS or low grade dysplasia (2009)
- Use of FTA card for dry collection, transportation and storage of cervical cell specimen to detect high-risk HPV (2009)
- Polymorphisms in 9q32 and TSCOT are linked to cervical cancer in affected sib-pairs with high mean age at diagnosis (2008)
- Variants of chemokine receptor 2 and interleukin 4 receptor, but not interleukin 10 or Fas ligand, increase risk of cervical cancer (2007)
- Identification of susceptibility loci for cervical carcinoma by genome scan of affected sib-pairs (2006)
- High viral loads of human papillomavirus predict risk of invasive cervical carcinoma. (2005)
- Type-specific associations of human papillomavirus load with risk of developing cervical carcinoma in situ. (2004)
- Real-time PCR-based system for simultaneous quantification of human papillomavirus types associated with high risk of cervical cancer (2003)